A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial

BACKGROUND: Diabetes affects over 20 million Americans, resulting in substantial morbidity, mortality, and costs. While medications are the cornerstone of secondary prevention, many evidence-based therapies are underutilized, and patients often cite out-of-pocket costs as the reason. Value-based ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaulding, Alicen, Fendrick, A Mark, Herman, William H, Stevenson, James G, Smith, Dean G, Chernew, Michael E, Parsons, Dawn M, Bruhnsen, Keith, Rosen, Allison B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673203/
https://www.ncbi.nlm.nih.gov/pubmed/19351413
http://dx.doi.org/10.1186/1748-5908-4-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673203/
https://www.ncbi.nlm.nih.gov/pubmed/19351413
http://dx.doi.org/10.1186/1748-5908-4-19

Ejemplares similares